• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前放化疗治疗局部进展期直肠癌能否预测病理完全缓解?

Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?

机构信息

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

出版信息

Int J Colorectal Dis. 2012 May;27(5):613-21. doi: 10.1007/s00384-011-1348-8. Epub 2011 Nov 15.

DOI:10.1007/s00384-011-1348-8
PMID:22080392
Abstract

BACKGROUND

Pathologic complete response has been proven to have oncological benefits for locally advanced rectal cancer treated with chemoradiation therapy. The aims of this study are to analyze and determine the factors to predict pathologic complete response for patients treated with preoperative neoadjuvant therapy.

METHODS

Patients with biopsy-proven, locally advanced rectal cancer were treated neoadjuvantly followed by radical surgical resection. Tumors were re-assessed after completing chemoradiation, including pelvic magnetic resonance images, colonoscopic examination, and re-biopsy. The results of examination were compared with the final pathologic status.

RESULTS

A retrospective chart review of 166 patients was conducted. Twenty-five patients (15.1%) had pathologic complete response after chemoradiation. The 5-year overall survival rates were better in the complete response group than the residual tumor group (91.1% vs. 70.8%; P = 0.047), and there were also significant differences in the 5-year disease-free survival rates between these two groups (91.1% vs. 70.2%; P = 0.027). The prediction rates for pathologic complete response by re-biopsy, magnetic resonance images, and colonoscopy were 21.4%, 33.3%, and 53.8%, respectively. In addition, when we further combine the results of colonoscopic findings and re-biopsy, the prediction rate for pathologic complete response reached 77.8% (P = 0.009).

CONCLUSIONS

Combining the results of the re-biopsy and post-treatment colonoscopic findings, we can achieve a good prediction rate for pathologic complete response. Post-treatment magnetic resonance images are not useful tools in predicting tumor clearance following chemoradiation.

摘要

背景

病理完全缓解已被证明对接受放化疗的局部晚期直肠癌具有肿瘤学益处。本研究旨在分析并确定预测接受术前新辅助治疗的患者病理完全缓解的因素。

方法

经活检证实患有局部晚期直肠癌的患者接受新辅助治疗,然后进行根治性手术切除。在完成放化疗后,重新评估肿瘤,包括盆腔磁共振成像、结肠镜检查和再次活检。将检查结果与最终病理状态进行比较。

结果

对 166 例患者进行了回顾性图表审查。25 例患者(15.1%)在放化疗后出现病理完全缓解。完全缓解组的 5 年总生存率优于残留肿瘤组(91.1% vs. 70.8%;P = 0.047),两组 5 年无病生存率也有显著差异(91.1% vs. 70.2%;P = 0.027)。再次活检、磁共振成像和结肠镜检查预测病理完全缓解的准确率分别为 21.4%、33.3%和 53.8%。此外,当我们进一步结合结肠镜检查结果和再次活检时,病理完全缓解的预测率达到 77.8%(P = 0.009)。

结论

结合再次活检和治疗后结肠镜检查结果,我们可以实现对病理完全缓解的良好预测率。治疗后磁共振成像不是预测放化疗后肿瘤清除的有用工具。

相似文献

1
Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?术前放化疗治疗局部进展期直肠癌能否预测病理完全缓解?
Int J Colorectal Dis. 2012 May;27(5):613-21. doi: 10.1007/s00384-011-1348-8. Epub 2011 Nov 15.
2
CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.CEA-预测直肠癌新辅助治疗后病理完全缓解的指标。
Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.
3
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.经新辅助放化疗后接受切除术的直肠癌患者,残留肿瘤负担评估的量化病理反应是无复发生存率的预测指标。
Cancer. 2013 Dec 15;119(24):4231-41. doi: 10.1002/cncr.28331. Epub 2013 Oct 1.
4
T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.晚期直肠癌术前放化疗后T分期降期和完全病理缓解可降低复发率并提高无病生存率。
Dis Colon Rectum. 2002 Jul;45(7):895-903. doi: 10.1007/s10350-004-6325-7.
5
Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?最终TNM分期是否是局部晚期直肠癌术前放化疗后生存情况的预测指标?
Ann Surg Oncol. 2007 Oct;14(10):2766-72. doi: 10.1245/s10434-007-9471-z. Epub 2007 Jun 6.
6
Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.黏液组织学对直肠癌中基于卡培他滨的新辅助放化疗后病理完全缓解率的预测意义:一项对比研究
J Gastrointest Cancer. 2019 Dec;50(4):716-722. doi: 10.1007/s12029-018-0136-x.
7
Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.直肠癌的病理完全缓解:我们能检测到吗?从一项拟议的直肠癌观察等待治疗随机试验中吸取的教训。
Dis Colon Rectum. 2016 Apr;59(4):255-63. doi: 10.1097/DCR.0000000000000558.
8
Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.局部晚期低位直肠癌新辅助放化疗后经肛门内括约肌间切除术行结肠肛管吻合术的长期肿瘤学结果。
Dis Colon Rectum. 2019 Apr;62(4):408-416. doi: 10.1097/DCR.0000000000001321.
9
Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.新辅助放化疗后肿瘤完全缓解的直肠癌患者的淋巴结疾病:平静水面下的危险
Dis Colon Rectum. 2017 Dec;60(12):1260-1266. doi: 10.1097/DCR.0000000000000947.
10
Complete Pathologic Response Prediction by Radiomics Wavelets Features of Unenhanced CT Simulation Images in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiation.基于增强 CT 模拟图像纹理波分析预测局部进展期直肠癌新辅助放化疗后完全病理缓解
Isr Med Assoc J. 2021 Dec;23(12):805-810.

引用本文的文献

1
Imaging Assessment of the Response to Neoadjuvant Treatment in Rectal Cancer in Relation to Postoperative Pathological Outcomes.直肠癌新辅助治疗反应的影像学评估与术后病理结果的关系
Curr Health Sci J. 2024 Oct-Dec;50(5):585-598. doi: 10.12865/CHSJ.50.04.13. Epub 2024 Dec 31.
2
Enhancing clinical complete response assessment in rectal cancer: integrating transanal multipoint full-layer puncture biopsy criteria: a systematic review.提高直肠癌临床完全缓解评估:整合经肛门多点全层穿刺活检标准:一项系统评价
Front Oncol. 2024 Dec 20;14:1428583. doi: 10.3389/fonc.2024.1428583. eCollection 2024.
3
Local excision versus total mesorectal excision for rectal cancer patients with clinical complete or near-complete response after neoadjuvant chemoradiotherapy.

本文引用的文献

1
Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.磁共振成像检测的局部晚期直肠癌肿瘤反应预测生存结局:MERCURY 经验。
J Clin Oncol. 2011 Oct 1;29(28):3753-60. doi: 10.1200/JCO.2011.34.9068. Epub 2011 Aug 29.
2
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.直肠癌放化疗后病理完全缓解患者的长期预后:个体患者数据的汇总分析。
Lancet Oncol. 2010 Sep;11(9):835-44. doi: 10.1016/S1470-2045(10)70172-8. Epub 2010 Aug 6.
3
Cancer statistics, 2010.
局部切除与全直肠系膜切除治疗新辅助放化疗后临床完全或接近完全缓解的直肠癌患者。
Int J Colorectal Dis. 2024 Oct 8;39(1):157. doi: 10.1007/s00384-024-04720-w.
4
Interaction between intratumoral microbiota and tumor mediates the response of neoadjuvant therapy for rectal cancer.肿瘤内微生物群与肿瘤之间的相互作用介导了直肠癌新辅助治疗的反应。
Front Microbiol. 2023 Oct 12;14:1229888. doi: 10.3389/fmicb.2023.1229888. eCollection 2023.
5
Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications.评估新辅助放化疗后直肠腺癌的临床和病理完全缓解及其治疗意义。
Rom J Morphol Embryol. 2021 Apr-Jun;62(2):411-425. doi: 10.47162/RJME.62.2.07.
6
High-Resolution T2-Weighted MRI to Evaluate Rectal Cancer: Why Variations Matter.高分辨率T2加权磁共振成像评估直肠癌:为何差异至关重要。
Korean J Radiol. 2021 Sep;22(9):1475-1480. doi: 10.3348/kjr.2021.0560.
7
Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm.局部晚期直肠癌的个性化治疗:将病理、分子遗传和免疫生物标志物纳入多模式治疗模式
Front Oncol. 2020 Aug 14;10:1369. doi: 10.3389/fonc.2020.01369. eCollection 2020.
8
MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.MRI 评估直肠癌术前放化疗的完全缓解:韩国腹部放射学会 2020 年实践指南。
Korean J Radiol. 2020 Jul;21(7):812-828. doi: 10.3348/kjr.2020.0483.
9
Combination Assessment of Clinical Complete Response of Patients With Rectal Cancer Following Chemoradiotherapy With Endoscopy and Magnetic Resonance Imaging.内镜检查与磁共振成像联合评估直肠癌患者放化疗后的临床完全缓解情况
Ann Coloproctol. 2019 Aug;35(4):202-208. doi: 10.3393/ac.2018.10.15. Epub 2019 Aug 31.
10
Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.基于内镜检查和磁共振成像对接受放化疗的直肠癌患者ypT分期的预测:110例患者的前瞻性研究结果
Medicine (Baltimore). 2019 Aug;98(35):e16614. doi: 10.1097/MD.0000000000016614.
癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
4
Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)能否预测局部晚期直肠癌术前放化疗后直肠系膜筋膜的肿瘤清除情况?
Strahlenther Onkol. 2008 Sep;184(9):457-64. doi: 10.1007/s00066-008-1858-7. Epub 2008 Sep 19.
5
Radiation changes do not interfere with postchemoradiation restaging of patients with rectal cancer by FDG PET/CT before curative surgical therapy.放疗改变并不影响直肠癌患者在根治性手术治疗前通过氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)进行放化疗后再分期。
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):60-6. doi: 10.1016/j.ijrobp.2008.06.1944. Epub 2008 Oct 14.
6
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.新辅助治疗后病理完全缓解在局部晚期直肠癌中的预后价值:对566例ypCR患者的长期分析
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):99-107. doi: 10.1016/j.ijrobp.2007.12.019. Epub 2008 Apr 11.
7
Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?最终TNM分期是否是局部晚期直肠癌术前放化疗后生存情况的预测指标?
Ann Surg Oncol. 2007 Oct;14(10):2766-72. doi: 10.1245/s10434-007-9471-z. Epub 2007 Jun 6.
8
Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy.术前联合18-氟脱氧葡萄糖正电子发射断层扫描和计算机断层扫描评估原发性直肠癌对新辅助治疗反应的疗效
J Gastrointest Surg. 2007 Aug;11(8):961-9; discussion 969. doi: 10.1007/s11605-007-0170-7.
9
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.序贯氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)能够可靠地预测局部晚期直肠癌对新辅助放化疗的反应。
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93. doi: 10.1007/s00259-007-0426-1. Epub 2007 May 15.
10
Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.新辅助放化疗后c0期低位直肠癌非手术治疗的失败模式及生存情况
J Gastrointest Surg. 2006 Dec;10(10):1319-28; discussion 1328-9. doi: 10.1016/j.gassur.2006.09.005.